Oculo-facial rejuvenation is done to improve tightness of skin around the eyes. Enhancing or correcting the shape of eyebrows and wrinkles around the eyes are common procedures done in orbital or oculo rejuvenation. Oculo-facial surgeons’ are focused on developing non-invasive procedures as a response to increasing patient demands for improved results. Technology advancements have brought us with multiple light and injectable therapeutic modalities for tightening of skin, filling and relaxing wrinkles around the eyes.
The growing demand for minimally invasive procedures and minimal downtime with no or minimal adverse effects is expected to drive the oculo-facial rejuvenation market.
Find Out More about the Report Coverage
Oculo-facial rejuvenation market drivers and restraints:
Facial aging is a common problem these days. Facial aging is caused d by various factors like sun exposure, smoking and sometimes it is genetic. Increasing unhealthy lifestyle habits like smoking is a major causative agent of facial aging. Photo damage or repeated sun exposure follows smoking in worsening the effect. Furthermore, these factors also significantly and differentially impact volume and skin related facial aging. Growing technology advancements in developing minimally invasive techniques is going to drive the market over the forecast period.
Oculo-facial rejuvenation treatment is an alternative to invasive cosmetic surgeries which are costlier. In comparison to these cosmetic surgeries, filling agents and chemical peels are more consistent and inexpensive. The treatment cost for cosmetic surgery in the US is ten times more than facial rejuvenation done for eyes. For all these reasons the oculo-facial rejuvenation treatment is preferred over cosmetic surgery.
On the other side, there are certain factors that might obstruct the growth of the oculo-facial rejuvenation market. These include lack of skilled physicians to do the appropriate procedure. These techniques require high expertise and should not go wrong as they are sensitive techniques around the area like eyes. Another factor is the risk associated with agents like botulinum toxin and other chemicals used.
The COVID-19 impact on the oculo-facial rejuvenation market was adverse. Very few patients visiting the clinics for Oculo-facial Rejuvenation treatment resulted in limiting the market growth. However the effect is short-lived and is expected to recover by end of 2020.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Based on product type, Oculo-facial Rejuvenation market is segmented into the following:
- Botulinum toxin
- Filling agents
- Chemical peels
Based on end user Oculo-facial Rejuvenation market is segmented into the following:
- Dermatology Clinics
- Hospitals and Specialty Clinics
By product type, botulinum toxin products and filling agents are the most used products for oculo-facial rejuvenation due to their efficient results. Also, preference of clinically proven products among patients has increased the penetration of botulinum toxin agents and filling agents. Increasing popularity of laser equipment for eyebrow enhancing and or eyebrow correction is also expected to drive the growth of oculo-facial rejuvenation market. Among end users, dermatology clinics is expected to lead the market owning to maximum procedures being performed in independent dermatology clinics.
The oculo-facial rejuvenation market will rapidly grow over the forecast period owing to increased demand for cosmetic facial corrections with intense results with a short recovery time. North America and Europe will lead the oculo-facial rejuvenation market as these regions have advance clinics and adoption of oculo-facial rejuvenation procedure is also more compared to developing regions. These regions are also benefitted with well-established reimbursement policies that makes the penetration of these oculo facial correction techniques higher. Rise in the number of minimally invasive cosmetic procedures along with high per capita disposable income will further make these regions a lucrative market. Also, presence of many local key players in these regions expand the growth of oculo-facial rejuvenation market. East Asia and Oceania, are expected to be profitable markets over the forecast period due to growing popularity of facial rejuvenation among people.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Oculo-facial Rejuvenation market players:
Some of the main market players for Oculo-facial Rejuvenation are:
- Ipsen Pharma
- Pfizer Inc
- Merz Pharma Gmbh & Co. Kgaa
- Anika Therapeutics Inc.
- Cynosure Inc
- Revance Therapeutics Inc.
- Fibrocell Inc.
- Shandong Lightyear Biotechnology Co.,Ltd.
- Quanta System S.p.A
- Biotec Italia Srl
- DEKA M.E.L.A. S.r.l.
Explore Persistence Market Research’s expertise in promulgation of the business !
The report on oculo-facial rejuvenation market covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Historical Actual Market Size, 2015 - 2019
- Market Size & Forecast 2020 to 2030
- Supply & Demand Value Chain
- Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
- Market Drivers and Restraints
Regional analysis for oculo-facial rejuvenation market includes
- North America
- Latin America
- East Asia
- South Asia
- Middle East & Africa
Report on oculo-facial rejuvenation market highlights:
- Shifting industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size
- Recent industry trends
- Key competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.